Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis.

Ayinalem AlemuZebenay Workneh BitewGetu DiribaGetachew SeidShewki MogaSaro AbdellaEmebet GashuKirubel EshetuGetachew TolleraMesay Hailu DangissoBalako Gumi

Published in: PloS one (2023)

Isoniazid mono-resistant TB patients had high poor treatment outcome. Thus, determination of isoniazid resistance pattern for all bacteriologically confirmed TB cases is critical for successful treatment outcome. PROSPERO registration number: CRD42022372367.

Keyphrases

mycobacterium tuberculosis
end stage renal disease
pulmonary tuberculosis
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
mass spectrometry
solid phase extraction
molecularly imprinted